Emcure Pharma confirms GST Dept search operation, assures 'No Material Impact' on operations
Pune: Emcure Pharmaceuticals Limited has announced that the Goods & Services Tax Department, Mumbai, has conducted a search and seizure operation at the company's offices.
The search was carried out by the Assistant Commissioner of State Tax (D-0214), Investigation – B, Mumbai, under Section 67 of the Maharashtra Goods and Services Tax Act, 2017.
"We will continue to extend our support and furnish any further information as may be required," Emcure said.
It further confirmed that no official document indicating any adverse findings has been issued to date.
It also emphasized that there is no material impact on the Company’s financials, operations or other activities, due to said inspection.
Read also: Emcure Pharma Gets CDSCO Panel Nod to Conduct Phase IV Trial on Drospirenone Tablets
Established in 1981, Emcure Pharmaceuticals Ltd. is an Indian pharma company headquartered in Pune engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products. Emcure is an R&D driven company that develops and manufactures a wide range of differentiated pharmaceutical products designed to improve patient health and well-being across several major therapeutic areas. Emcure is present in 70+ countries globally including Europe and Canada.
Read also: Emcure Pharma reports 25 percent surge in profit after tax to Rs 251 crore in Q2
